Vir Biotechnology, Inc.: cashflow_investing
| Value | {"amount": 98079000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-03-31 |
| Status | current |
| Entity | Vir Biotechnology, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:28:03.755260+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/35b8a069-bd55-4b41-8c83-482a39970d90
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-23-018789Retrieved: 2026-08-19T17:28:03.755260+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001706431/cashflow-investing/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/35b8a069-bd55-4b41-8c83-482a39970d90
History
- no predecessors — first report